Chemoinformaics analysis of 1-Methyl-3,4-dihydroisoquinoline
Molecular Weight | 145.205 | nRot | 0 |
Heavy Atom Molecular Weight | 134.117 | nRig | 11 |
Exact Molecular Weight | 145.089 | nRing | 2 |
Solubility: LogS | -2.914 | nHRing | 1 |
Solubility: LogP | 2.641 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
nHA | 1 | APOL | 25.1347 |
nHD | 0 | BPOL | 12.1753 |
QED | 0.53 |
Synth | 2.268 |
Natural Product Likeliness | 0.225 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.005 |
Pgp-sub | 0.941 |
HIA | 0.003 |
CACO-2 | -4.49 |
MDCK | 0.0000344 |
BBB | 0.962 |
PPB | 0.603364 |
VDSS | 2.368 |
FU | 0.373773 |
CYP1A2-inh | 0.684 |
CYP1A2-sub | 0.906 |
CYP2c19-inh | 0.05 |
CYP2c19-sub | 0.563 |
CYP2c9-inh | 0.022 |
CYP2c9-sub | 0.387 |
CYP2d6-inh | 0.868 |
CYP2d6-sub | 0.876 |
CYP3a4-inh | 0.008 |
CYP3a4-sub | 0.435 |
CL | 7.683 |
T12 | 0.339 |
hERG | 0.042 |
Ames | 0.016 |
ROA | 0.601 |
SkinSen | 0.295 |
Carcinogencity | 0.099 |
EI | 0.937 |
Respiratory | 0.272 |
NR-Aromatase | 0.008 |
Antiviral | No |
Prediction | 0.864346 |